| Hemodynamic effects of recombinant human activated protein C in patients with septic shock. | |
| | |
MedLine Citation:
|
PMID: 19781904 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: The aim of this study is to examine the effects of recombinant human activated protein C (rhAPC) on hemodynamic parameters in patients with septic shock. METHODS: This is a retrospective study of 2 university-hospital critical care units. Patients with septic shock with pulmonary artery catheterization or transthoracic thermodilution monitoring were studied. We matched patients with septic shock with at least 2 organ failures (18 treated with rhAPC and 18 controls) on sex, age, sequential organ failure assessment (SOFA), Acute Physiology and Chronic Health Evaluation (APACHE) II, and sepsis etiology. We recorded norepinephrine dose and hemodynamic parameters at baseline and 24, 36, and 48 hours after the real or theoretical start of rhAPC treatment. RESULTS: Mean arterial pressure remained stable in both groups. In rhAPC patients, norepinephrine requirements, initially higher than in controls, were significantly lower at 48 hours, and stroke volume at 24 and 48 hours improved (P < .05). CONCLUSION: Recombinant human activated protein C use correlated with improved hemodynamic parameters and decreased norepinephrine requirements. The retrospective nature of the study limits the strength of these findings. |
| | |
Authors:
|
Baltasar Sanchez; Enrique Piacentini; Vittorio Pradella; Mariano Mignini; Juan Nava |
Related Documents
:
|
6740254 - Primary treatment of 50 patients with high-tension electrical injuries. i. fluid resusc... 10974364 - Pain perception during self-reported distress and calmness in patients with borderline ... 7798454 - Tonometry to assess the adequacy of splanchnic oxygenation in the critically ill patient. 18403124 - Galactorrhea and amenorrhea in burn patients. 10362194 - Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors... 3360334 - Fusion ability lost and regained in visual adults. |
Publication Detail:
|
Type: Journal Article Date: 2009-09-24 |
Journal Detail:
|
Title: Journal of critical care Volume: 25 ISSN: 1557-8615 ISO Abbreviation: J Crit Care Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-06-10 Completed Date: 2010-07-27 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8610642 Medline TA: J Crit Care Country: United States |
Other Details:
|
Languages: eng Pagination: 343-7 Citation Subset: IM |
Copyright Information:
|
Copyright (c) 2010 Elsevier Inc. All rights reserved. |
Affiliation:
|
Intensive Care Unit, Hospital Mútua deTerrassa, Terrassa, Spain. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
APACHE Case-Control Studies Catheterization, Swan-Ganz Female Hemodynamics / drug effects* Humans Male Middle Aged Norepinephrine / administration & dosage Protein C / pharmacology*, therapeutic use Recombinant Proteins / pharmacology*, therapeutic use Retrospective Studies Shock, Septic / drug therapy, physiopathology* Thermodilution Treatment Outcome Vasodilator Agents / pharmacology*, therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Protein C; 0/Recombinant Proteins; 0/Vasodilator Agents; 51-41-2/Norepinephrine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Delirium in patients admitted to a step-down unit: Analysis of incidence and risk factors.
Next Document: Real-time monitoring of heart rate variability in critically ill patients.